论文部分内容阅读
目的:探究双价肾综合征出血热灭活疫苗对狂犬病疫苗免疫和临床效果。方法:资料随机选自2011年4月～2013年4月在疾控中心门诊就诊的患者200例,将患者按照随机数字表方法分为两组,每组100例,将猫、犬致伤且采用单纯接种的狂犬疫苗者作为对照组,鼠致伤且采用双价肾综合征出血热灭活疫苗者作为研究组,并分析患者的治疗后出现的副反应程度情况。结果:经不同方案的治疗后,研究组研究组患者的发生率为4.0%,对照组患者的发生率为16.0%,两组比较差异明显,具统计学上的意义(P<0.05)。结论:通过采用双价肾综合征出血热灭活疫苗来治疗狂犬病患者,能够有效改善患者的症状,提高治愈率。
Objective: To investigate the immunization and clinical effect of rabies vaccine on inactivated vaccine of divalent renal syndrome. Methods: The data were randomly selected from 200 outpatients in CDC clinic from April 2011 to April 2013. The patients were divided into two groups according to the random number table method, 100 cases in each group. The cats and dogs were injured Using rabies vaccine alone inoculated rabies vaccine as a control group, mice were killed and treated with the vaccine of hemorrhagic fever with diarrheal syndrome were used as the study group, and the degree of side effects after treatment were analyzed. Results: After treatment with different regimens, the incidence rate of study group was 4.0% and that of control group was 16.0%. There was significant difference between the two groups with statistical significance (P <0.05). CONCLUSIONS: Rabies patients treated with hemorrhagic fever with dengue virus syndrome can effectively improve their symptoms and cure rate.